Zobrazeno 1 - 10
of 14
pro vyhledávání: '"MESH: Antibodies, Neoplasm"'
Autor:
Cecile Artaud, Marie-Paule Sablin, Jacques Medioni, Pierre Rosenbaum, Sylvie Bay, Olivier Tredan, Christelle Ganneau, Suzette Delaloge, Delphine Loirat, Mario Campone, François Pein, Claude Leclerc, Andrea Varga, Carole Gourmelon
Publikováno v:
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2020, 69 (5), pp.703-716. ⟨10.1007/s00262-020-02503-0⟩
Cancer Immunology, Immunotherapy, 2020, 69 (5), pp.703-716. ⟨10.1007/s00262-020-02503-0⟩
Cancer Immunology, Immunotherapy, Springer Verlag, 2020, 69 (5), pp.703-716. ⟨10.1007/s00262-020-02503-0⟩
Cancer Immunology, Immunotherapy, 2020, 69 (5), pp.703-716. ⟨10.1007/s00262-020-02503-0⟩
International audience; Cancer is one of the main causes of mortality worldwide and a major public health concern. Among various strategies, therapeutic vaccines have been developed to stimulate anti-tumoral immune responses. However, in spite of ext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78818bcefd52ce7613a01537f7dfaf47
https://hal-pasteur.archives-ouvertes.fr/pasteur-03329313
https://hal-pasteur.archives-ouvertes.fr/pasteur-03329313
Autor:
Vahan Kepenekian, Veronique Saywell, Laurent Villeneuve, Benoit You, Pierre Liaud, Berengere Vire, Frederic Mercier, Delphine Maucort-Boulch, Winston Tan, Alexandre Prieur, Julien Soulé, Maud Flacelière, Philippe Elies, Manish Kohli, Olivier Glehen, Carole Langlois-Jacques, Fanny Belouin, Dominique Joubert, Thibault Mazard, E. Assenat, Marc Ychou, Lea Payen, Eric Morency, Marie Dupuy
Publikováno v:
EBioMedicine
EBioMedicine, 2020, 51, pp.102574. ⟨10.1016/j.ebiom.2019.11.035⟩
EBioMedicine, Elsevier, 2020, 51, pp.102574. ⟨10.1016/j.ebiom.2019.11.035⟩
EBioMedicine, Vol 51, Iss, Pp-(2020)
EBioMedicine, 2020, 51, pp.102574. ⟨10.1016/j.ebiom.2019.11.035⟩
EBioMedicine, Elsevier, 2020, 51, pp.102574. ⟨10.1016/j.ebiom.2019.11.035⟩
EBioMedicine, Vol 51, Iss, Pp-(2020)
Background: In colorectal cancer, hPG80 (progastrin) is released from tumor cells, promotes cancer stem cells (CSC) self-renewal and is detected in the blood of patients. Because the gene GAST that encodes hPG80 is a target gene of oncogenic pathways
Autor:
André Nicolas, Otto Pritsch, Sophie Viel, Sebastian Amigorena, Pablo Oppezzo, Adele Heitzmann, Xavier Sastre-Garau, Pascale Hubert, Eduardo Osinaga
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. ⟨10.1158/0008-5472.CAN-10-4222⟩
Cancer Research; Vol 71
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. 〈10.1158/0008-5472.CAN-10-4222〉
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. ⟨10.1158/0008-5472.CAN-10-4222⟩
Cancer Research; Vol 71
Cancer Research, American Association for Cancer Research, 2011, 71 (15), pp.5134-43. 〈10.1158/0008-5472.CAN-10-4222〉
Antibody-dependent cell cytotoxicity (ADCC) plays a critical role in monoclonal antibody (mAb)-mediated cancer therapy. ADCC, however, has not been directly shown in vivo but inferred from the requirement for IgG Fc receptors (FcγR) in tumor rejecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332f9cf0fa60a2116b3cc261a15b7592
https://hal-riip.archives-ouvertes.fr/pasteur-00685062
https://hal-riip.archives-ouvertes.fr/pasteur-00685062
Autor:
Otto Pritsch, Renaud Du Pasquier, Alberto Roseto, Eduardo Osinaga, Alvaro Babino, Pedro M. Alzari, Pablo Oppezzo
Publikováno v:
HYBRIDOMA
HYBRIDOMA, Mary Ann Liebert, 1997, 16 (4), pp.317-324. ⟨10.1089/hyb.1997.16.317⟩
HYBRIDOMA, 1997, 16 (4), pp.317-324. ⟨10.1089/hyb.1997.16.317⟩
HYBRIDOMA, Mary Ann Liebert, 1997, 16 (4), pp.317-324. ⟨10.1089/hyb.1997.16.317⟩
HYBRIDOMA, 1997, 16 (4), pp.317-324. ⟨10.1089/hyb.1997.16.317⟩
International audience; We report here the first amino acid sequence of an anti-Tn monoclonal antibody raised against human breast cancer cells and show that a single chain Fv fragment of this IgM retains the Tn-binding specificity as defined by func
Autor:
Gaborit, Nadège, Larbouret, Christel, Vallaghe, Julie, Peyrusson, Frédéric, Bascoul-Mollevi, Caroline, Crapez, Evelyne, Azria, David, Chardes, Thierry, Poul, Marie-Alix, Mathis, Gérard, Bazin, Hervé, Pèlegrin, André
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (13), pp.11337-45. ⟨10.1074/jbc.M111.223503⟩
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (13), pp.11337-45. ⟨10.1074/jbc.M111.223503⟩
International audience; In oncology, simultaneous inhibition of epidermal growth factor receptor (EGFR) and HER2 by monoclonal antibodies (mAbs) is an efficient therapeutic strategy but the underlying mechanisms are not fully understood. Here, we des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8daf37e8f6a66ce45698473c976e989a
https://www.hal.inserm.fr/inserm-00576598/file/supplemental_data.pdf
https://www.hal.inserm.fr/inserm-00576598/file/supplemental_data.pdf
Autor:
Gaborit, Nadège, Larbouret, Christel, Vallaghe, Julie, Peyrusson, Frédéric, Bascoul-Mollevi, Caroline, Crapez, Evelyne, Azria, David, Chardes, Thierry, Poul, Marie-Alix, Mathis, Gérard, Bazin, Hervé, Pèlegrin, André
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (13), pp.11337-45. ⟨10.1074/jbc.M111.223503⟩
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2011, 286 (13), pp.11337-45. ⟨10.1074/jbc.M111.223503⟩
International audience; In oncology, simultaneous inhibition of epidermal growth factor receptor (EGFR) and HER2 by monoclonal antibodies (mAbs) is an efficient therapeutic strategy but the underlying mechanisms are not fully understood. Here, we des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::8daf37e8f6a66ce45698473c976e989a
https://doi.org/10.1074/jbc.M111.223503
https://doi.org/10.1074/jbc.M111.223503
Autor:
Hernandez, Sonia, Tsuchiya, Yo, García-Ruiz, Josefa, Lalioti, Vassiliki, Nielsen, Søren, Cassio, Doris, Sandoval, Ignacio
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2008, 134 (4), pp.1215-23. ⟨10.1053/j.gastro.2008.01.043⟩
Gastroenterology, WB Saunders, 2008, 134 (4), pp.1215-23. ⟨10.1053/j.gastro.2008.01.043⟩
International audience; BACKGROUND & AIMS: The copper transporter ATP7B plays a central role in the elimination of excess copper by the liver into the bile, yet the site of its action remains controversial. The studies reported here examine the corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::147c0a11f67274585adb9b62b367b6d1
https://www.hal.inserm.fr/inserm-00276812/file/Hernandez_2008_gastro.pdf_-1.pdf
https://www.hal.inserm.fr/inserm-00276812/file/Hernandez_2008_gastro.pdf_-1.pdf
Autor:
Hernandez, Sonia, Tsuchiya, Yo, García-Ruiz, Josefa, Lalioti, Vassiliki, Nielsen, Søren, Cassio, Doris, Sandoval, Ignacio
Publikováno v:
Gastroenterology
Gastroenterology, Elsevier, 2008, 134 (4), pp.1215-23. ⟨10.1053/j.gastro.2008.01.043⟩
Gastroenterology, Elsevier, 2008, 134 (4), pp.1215-23. ⟨10.1053/j.gastro.2008.01.043⟩
International audience; BACKGROUND & AIMS: The copper transporter ATP7B plays a central role in the elimination of excess copper by the liver into the bile, yet the site of its action remains controversial. The studies reported here examine the corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::147c0a11f67274585adb9b62b367b6d1
https://www.hal.inserm.fr/inserm-00276812/file/Hernandez_2008_gastro.pdf_-1.pdf
https://www.hal.inserm.fr/inserm-00276812/file/Hernandez_2008_gastro.pdf_-1.pdf
Autor:
Antoine Gessain, Renaud Mahieux
Publikováno v:
Current hematologic malignancy reports
Current hematologic malignancy reports, 2007, 2 (4), pp.257-64. ⟨10.1007/s11899-007-0035-x⟩
Current hematologic malignancy reports, 2007, 2 (4), pp.257-64. ⟨10.1007/s11899-007-0035-x⟩
International audience; Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million individuals worldwide. This oncoretrovirus can be transmit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3574a0a96ec14a999d902d6369955a7f
https://hal-pasteur.archives-ouvertes.fr/pasteur-00531344
https://hal-pasteur.archives-ouvertes.fr/pasteur-00531344
Autor:
Ludovic Canelle, Geneviève Choquet-Kastylevsky, Michel Caron, Jean-Paul Lasserre, Raymonde Joubert-Caron, Céline Vlieghe, Julie Hardouin, Magalie Duchateau
Publikováno v:
Journal of Separation Science
Journal of Separation Science, Wiley-VCH Verlag, 2007, 30 (3), pp.352-358. ⟨10.1002/jssc.200600324⟩
Journal of Separation Science, 2007, 30 (3), pp.352-358. ⟨10.1002/jssc.200600324⟩
Journal of Separation Science, Wiley-VCH Verlag, 2007, 30 (3), pp.352-358. ⟨10.1002/jssc.200600324⟩
Journal of Separation Science, 2007, 30 (3), pp.352-358. ⟨10.1002/jssc.200600324⟩
International audience; Patients with cancer produce specific autoantibodies against protein antigens present in limited amount among a large background of immunoglobulins (Igs), nonrelevant as biomarkers, including natural antibodies. Multiple affin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be247fcd909e5617af6a4dd2595288b7
https://hal.archives-ouvertes.fr/hal-03157407
https://hal.archives-ouvertes.fr/hal-03157407